Company / Shareholders' Equity
Ensign Group Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$2.2B
FY2025
5-year range
$1.0B / $2.2B
FY2021-FY2025
Trend
+21.5%
vs FY2024
Sector context
#50 of 161
Health Care
What the data says
At $2.2B, Ensign Group's shareholders' equity ranks #50 of 161 in the Health Care sector. Shareholders' Equity has increased for 9 consecutive years, from $456M in FY2016 to $2.2B in FY2025.
Based on SEC 10-K filings.
$2.2B in FY2025 with a 5-year CAGR of +22.2%.
Improved from $1.5B to $2.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +21.4%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
#50 of 161 in Health CareTop 31% of 161This company $2.2B Sector average $5.1B
▼
-55.9% below sector average
Key checks
Key Insights
- Ensign Group's shareholders' equity has grown for 9 consecutive years.
- 5-year CAGR of +22.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 21.5% year-over-year.
- Ranks #50 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2B | +21.5% |
| FY2024 | $1.8B | +23.1% |
| FY2023 | $1.5B | +19.6% |
| FY2022 | $1.2B | +22.2% |
| FY2021 | $1.0B | +24.8% |
| FY2020 | $818.1M | +25.1% |
| FY2019 | $654.2M | +10.7% |
| FY2018 | $590.9M | +20.0% |
| FY2017 | $492.4M | +7.9% |
| FY2016 | $456.4M | +6.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026